How the Senate's CHIPS-plus bill ballooned by billions
Add Axios as your preferred source to
see more of our stories on Google.
Illustration: Shoshana Gordon/Axios
Once Senate leaders opened the door to moving on a China competitiveness bill over the weekend, a bipartisan group of senators knew exactly what it had to do: use the slimmed-down package as a shell to stuff in as many priorities as possible.
Why it matters: The emerging legislation goes far beyond the narrow $52 billion bill to shore up domestic semiconductor manufacturing that even the Biden administration was willing to settle for this month.
- After a week of maneuvering from Sens. Kyrsten Sinema (D-Ariz.) and Todd Young (R-Ind.), the new legislation more closely resembles the $250 billion bill the Senate passed last summer.
- "There were very, very few changes from what they had previously voted on," Sen. Maria Cantwell (D-Wash.), who also was involved, told Axios. "This really is what we passed out of the Senate."
Driving the news: The U.S. Innovation and Competitiveness Act (USICA) was on life support this month after Senate Minority Leader Mitch McConnell (R-Ky.) threatened to tank the bill if Democrats pursued a robust reconciliation package reviving President Biden's Build Back Better agenda.
- But once Sen. Joe Manchin (D-W.Va.) killed a big reconciliation bill, GOP leaders quietly walked back McConnell's threat.
- Sinema and Young swung into action and corralled a group of Senate Republicans and Democrats to load billions onto CHIPS-plus — while also managing to keep McConnell on board.
Yes, but: The Senate's latest version still needs sign-off from the House, which had deep reservations about accepting the original USICA.
- It's unclear if the House will buy the clever USICA rebrand and vote for it just because Washington now calls it "CHIPS-plus."
- Already, the largest bloc of House conservatives has begun circulating a memo slamming the package as a "fake China bill" and a "zombie" version of USICA.
Between the lines: In the Senate, the nascent deal allows all sides to claim victory.
- Senate Majority Leader Chuck Schumer (D-N.Y.) has a big, beefy China bill heading for approval, along with a reconciliation package to lower prescription drugs and shore up Obamacare health exchanges. That's two potential August wins before a November election.
- McConnell can claim he forced Democrats to abandon their spending ambitions on climate while giving the China bill — which the business community desperately wants and which he voted for — a second chance.
The big picture: Several senators told Axios they were spooked after a classified briefing with Commerce Secretary Gina Raimondo and defense and intelligence officials on July 13 that detailed the national security risks of not acting.
- "Everybody got a glimpse of what was at stake," Cantwell said. The overarching sentiment was that the Senate "should do more than just CHIPS," she added.
Behind the scenes: At 6pm Monday night, Sinema and Young gathered members who care deeply about USICA — in addition to the majority of the 20 senators involved in passing the bipartisan infrastructure and gun safety bills — for a meeting in the Capitol's LBJ room.
- The provisions getting cut were crucial to national security, they stressed.
- Cantwell and Roger Wicker (R-Miss.), the top two senators on the Senate Commerce, Science and Transportation Committee, ensured that funding for science and technology programs was made a priority.
- Young, after meeting alone with Senate Republicans, realized that some GOP senators' votes depended on making the bill bigger, a source with direct knowledge of the meeting told Axios.
- "I'm not sure they would have had 60 votes for CHIPS only," they said. "There were a number of members who weren't really comfortable just moving forward with that on its own."
Be smart: Schumer ultimately made the decision to put a bigger package that included most, but not all, of the priorities in USICA on the floor for a procedural vote Tuesday night — calling it a test vote.
- After Sinema and Young aggressively whipped senators to support the bill, the motion to proceed passed 64-34, with 16 Senate Republican votes.
The bottom line: The eleventh-hour meeting is the latest example of how — even in a 50-50 Senate — a rotating stable of bipartisan brokers has found success pushing major legislation over the finish line when a deal has initially seemed impossible.
By the numbers: A new preliminary score from the Congressional Budget Office assessed that the bill will cost roughly $79 billion in direct spending over 10 years.
- The remainder of spending will be through the authorization of money that's already been appropriated, policy aides working on the bill tell Axios.
- The CBO is planning to provide a 10-year estimate including the authorizations in the coming days.
Go deeper: Read the full bill text and a five-page summary.
